Delivery Order SPE2DE24D0013-SPE2D625F1AYH
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Defense Department's Medical Supply Chain division awarded a $17,280 firm fixed-price delivery order to Cepheid Inc. on August 27, 2025, with an ultimate completion date of September 4, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems and test kits, was selected without a set-aside...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The Defense Logistics Agency awarded a $13.6K delivery order to Cepheid Inc. for the Xpert Xpress COVID-19/Flu/RSV molecular diagnostic kit on September 25, 2025. This firm fixed-price contract, with performance in Sunnyvale, California, represents a single delivery order with no set-aside designation. Cepheid, a leading manufacturer of molecular diagnostic solutions, supplies rapid point-of-care testing kits designed to detect multiple respiratory pathogens simultaneously, supporting the...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1AYHDelivery Order
The Defense Department's Medical Supply Chain awarded Cepheid a $6.8K firm fixed-price delivery order on August 14, 2025, for the XpertXpress COVID-19, Flu, RSV, and molecular biology test kit. This delivery order represents a single procurement action under one of Cepheid's larger indefinite delivery vehicles with the Department of Veterans Affairs (VA), which provides ongoing access to the company's molecular diagnostic testing systems and reagents. The contract is set to complete by August 19, 2025, with performance taking place at Cepheid's facility in Sunnyvale, California. No set-aside designation applies to this award. Cepheid is a for-profit manufacturer specializing in molecular diagnostic solutions and has established itself as a key federal supplier through multiple contracts with the VA, Defense Logistics Agency (DLA), and other defense health entities. The company's GeneXpert diagnostic systems and associated test kits are designed to detect infectious diseases including COVID-19, influenza, and respiratory syncytial virus (RSV), meeting ongoing clinical laboratory requirements across federal healthcare systems. This award continues Cepheid's service delivery under existing federal vehicle contracts that support diagnostic testing capabilities within the defense and veterans healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/14/25 |